Skip to content

NPS PHARMACEUTICALS INC: filings

Every NPS PHARMACEUTICALS INC annual and quarterly report in the SEC record with the published financial measures it tagged, 15 filings, each linked to its SEC index.

Filing record ends 2015-02-18

The latest filing in this captured record is a 10-K filed 2015-02-18. No later filing is in the SEC companyfacts record captured on 2026-09-22. NPS PHARMACEUTICALS INC may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-K2015-02-18fiscal FY 2014441510001136261-15-000049
10-Q2014-11-10fiscal Q3 2014371060001136261-14-000479
10-Q2014-08-06fiscal Q2 2014401130001136261-14-000357
10-Q2014-05-08fiscal Q1 201439800001136261-14-000183
10-K2014-02-18fiscal FY 2013451550001136261-14-000082
10-Q2013-11-06fiscal Q3 2013391100001136261-13-000499
10-Q2013-08-08fiscal Q2 2013391100001136261-13-000348
10-Q2013-05-09fiscal Q1 201337760001136261-13-000211
10-K2013-02-21fiscal FY 2012401350001136261-13-000114
10-Q2012-11-09fiscal Q3 2012341000001136261-12-000592
10-Q2012-08-01fiscal Q2 2012341000001136261-12-000429
10-Q2012-05-03fiscal Q1 201232660001136261-12-000251
10-K2012-02-15fiscal FY 201133860001136261-12-000104
10-Q2011-11-03fiscal Q3 201132920001136261-11-000570
10-Q2011-08-02fiscal Q2 201132920001136261-11-000450

Inspect the source

Entity
NPS PHARMACEUTICALS INC / CIK 0000890465
Captured
SEC response SHA-256
7d6d48126ad30927f73519842e4e7850d1723b99d58b6d67e7b74ebacdb98780

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000890465.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))